[12. Sethi NJ, Safi S, Korang SK, et al. Antibiotics for secondary prevention of coronary heart disease. Cochrane Database of Systematic Reviews. 2017;7:CD003610. doi: 10.1002/14651858. CD003610.pub3.10.1002/14651858.CD003610.pub3]Open DOISearch in Google Scholar
[13. World Health Organization. Cardiovascular Diseases fact sheet (updated May 2017). Available at: http://www.who.int/mediacentre/factsheets/fs317/en/]Search in Google Scholar
[14. Hamilton JA, Hasturk H, Kantarci A, Serhan CN, Van Dyke T. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins. Curr Atheroscler Rep. 2017;19:57. doi: 10.1007/s11883-017-0696-4.10.1007/s11883-017-0696-4]Open DOISearch in Google Scholar
[15. Theodora Benedek. The Link between Periodontal Disease, Inflammation and Atherosclerosis – an Interdisciplinary Approach. Journal of Interdisciplinary Medicine. 2017;2(S1):11-16. doi: 1.0.1515/jim-2017-0016.10.1515/jim-2017-0016]Search in Google Scholar
[16. Lawson JS. Multiple Infectious Agents and the Origins of Atherosclerotic Coronary Artery Disease. Front Cardiovasc Med. 2016;3:30. doi:10.3389/fcvm.2016.00030.10.3389/fcvm.2016.00030]Open DOISearch in Google Scholar
[17. B Kalra DK, Heo R, Valenti V, Nakazato R, Min JK. Role of Computed Tomography for Diagnosis and Risk Stratification of Patients with Suspected or Known Coronary Artery Disease. Arterioscler Thromb Vasc Biol. 2014;34:1144-1154. doi: 10.1161/ATVBAHA.113.302074.10.1161/ATVBAHA.113.302074]Open DOISearch in Google Scholar
[18. Fatkhullina AR, Peshkova IO, Koltsova EK. The Role of Cytokines in the Development of Atherosclerosis. Biochemistry (Mosc). 2016;81:1358-1370. doi: 10.1134/S0006297916110134.10.1134/S0006297916110134]Open DOISearch in Google Scholar
[19. Hansen GM, Egeberg A, Holmstrup P, Hansen PR. Relation of Periodontitis to Risk of Cardiovascular and All-Cause Mortality (From a Danish Nationwide Cohort Study). Am J Cardiol. 2016;118:489-493. doi: 10.1016/j.amjcard.2016.05.036.10.1016/j.amjcard.2016.05.036]Open DOISearch in Google Scholar
[20. Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017;11:72-80.]Search in Google Scholar
[21. Gualtero DF, Lafaurie GI, Fontanilla MR. Two-dimensional (2D) and three-dimensional (3D) models for studying atherosclerosis pathogenesis induced by periodontopathogenic microorganisms. Mol Oral Microbiol. 2017. doi: 10.1111/omi.12201.10.1111/omi.12201]Open DOISearch in Google Scholar
[22. Martu S, Nicolaiciuc O, Solomon S, et al. The Evaluation of the C Reactive Protein Levels in the Context of the Periodontal Pathogens Presence in Cardiovascular Risk Patients. Revista de Chimie. 2017;68:605-607.10.37358/RC.17.5.5616]Search in Google Scholar
[23. Fonseca FAH, de Oliveira Izar MC. High-Sensitivity C-Reactive Protein and Cardiovascular Disease Across Countries and Ethnicities”. Clinics (Sao Paulo). 2016;71:235-242. doi: 10.6061/clinics/2016(04)11.10.6061/clinics/2016(04)11]Open DOISearch in Google Scholar
[24. Assadpour Piranfar M. The Correlation between High-Sensitivity C-Reactive Protein (hsCRP) Serum Levels and Severity of Coronary Atherosclerosis. Int Cardiovasc Res J. 2014;8:6-8.]Search in Google Scholar
[25. van Soesta G, Marcub L, Boumac BE, Regardet E. Intravascular imaging for characterization of coronary atherosclerosis. Current Opinion in Biomedical Engineering. 2017;3:1-12. doi. org/10.1016/j.cobme.2017.07.001.10.1016/j.cobme.2017.07.001]Open DOISearch in Google Scholar
[26. Libby P, Theroux P. Pathophysiology of Coronary Artery Disease. Circulation. 2005;111:3481-3488. doi: 10.1161/CIRCULATIONAHA.105.537878.10.1161/CIRCULATIONAHA.105.53787815983262]Open DOISearch in Google Scholar